Lifestream Technologies Receives Increased Term Note Payable Amid Market Concerns

Lifestream Technologies, Inc. (OTC BB: LFTC), a leading supplier of cholesterol monitors, announced an increase in its term note payable of $1.5 million, to be funded over the next two months. The Company's CEO, Christopher Maus, expressed satisfaction with the lenders' decision, citing concerns over equity financing and the benefits of conventional debt financing. This move aims to calm market concerns and position Lifestream for future financial stability.

Key Takeaways:

• Lifestream Technologies, Inc. (OTC BB: LFTC) received an increase in its term note payable of $1.5 million, to be funded over the next two months.
• The loan comes with a moratorium on repayment for six months, allowing the Company to build inventory and support operational requirements.
• Lifestream's CEO, Christopher Maus, believes that this conventional debt financing will mitigate the need for future equity financings and help address market concerns.
• The Company's cholesterol monitors are hand-held, affordable devices that provide test results in three minutes, aiding health-conscious consumers in monitoring their risk of heart disease.
• Lifestream's products integrate a smart card reader for storing test results on an individual's personal health card for future retrieval, trend analysis, and assessment.

Statistics:

• $1.5 million: The increase in Lifestream Technologies, Inc.'s term note payable.
• 2 months: The duration over which the loan will be funded.
• 6 months: The moratorium period on repayment of the amended term note.
• 3 minutes: The time it takes for Lifestream's cholesterol monitors to provide test results.
• $52,000: The proceeds from the sale of 1.7 million shares of Lifestream Technologies, Inc. stock by Market Pulse.
• September 2004: Market Pulse sold 1 million shares of Lifestream Technologies, Inc. stock for $25,000.

Sources:

• Market Wire via COMTEX
• Market Pulse News Alert